A hexamethylenediamine high-yield strain and preparation method thereof
By constructing high-yield hexadiene strains expressing carboxylic acid reductase mutants and diaminogenase in engineering strains, the problem of failure to construct the 1,6-hexadiene metabolic synthesis path in the prior art was solved, and high yields were achieved 1,6-hexanediamine biosynthesis has good industrial application prospects.
Patent Information
- Application Number
- CN202311855614.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-12-29
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2043-12-29
AI Technical Summary
The prior art has failed to construct a complete 1,6-hexanediamine metabolic synthesis pathway in engineered bacteria, and no natural 1,6-hexanediamine biosynthesis pathway has been reported.
Constructed high-yield hexadiene strains expressing carboxylic acid reductase mutants MAB CAR L342E, aminotransferase PatA and aminotransferase VFTA. By optimizing the expression of these enzymes, 1,6-hexadiene was constructed with 6-aminocaproic acid as the substrate. Biosynthesis pathway.
The yield of 1,6-hexanediamine has been significantly improved, providing good industrial application prospects, and the expression of the double aminotransferase gene is significantly higher than that of the single aminotransferase strain, providing a new biosynthesis pathway.
Smart Images

Figure CN118185844B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of biosynthesis of 1,6-hexanediamine, and in particular to a hexanediamine high-yield strain and a preparation method thereof. Background Art
[0002] At present, some studies have constructed an artificial synthesis pathway of 1,6-hexanediamine using biological enzyme catalysis. For example, reference 1 (LAUM K. Methods and microorganisms for the biological synthesis of (s)-2-amino-6-hydroxypimelate, hexamethylenediamine and 6-aminocaproate [Z]. Google Patents. 2015) discloses a biocatalytic pathway from glutamate to 1,6-hexanediamine; reference 2 (FEDORCHUK TP, KHUSNUTDINOVA AN, EVDOKIMOVA E, et al. One-Pot Biocatalytic Transformation of Adipic Acid to 6-Aminocaproic Acid and 1,6-Hexamethylenediamine Using Carboxylic Acid Reductases and Transaminases [J]. J Am Chem Soc, 2020, 142(2):1038-48.) disclosed the biotransformation pathway of adipic acid to 1,6-hexanediamine, successfully achieved the biotransformation of adipic acid to 1,6-hexanediamine in vitro, and obtained a yield of 3mM; Document 3 (ZHANG Z, FANG L, WANG F, et al. Transforming Inert Cycloalkanes into α, ω-Diamines by Designed Enzymatic Cascade Catalysis[J]. Angewandte Chemie International Edition, 2023, 62(16):e202215935.) constructed three different modules, using cyclohexane and cyclohexanol as substrates, respectively, to synthesize 7.6mM and 16.5mM of 1,6-hexanediamine. Reference 4 (Shi Kun, Yu Huilei, Xu Jianhe. Research progress of carboxylic acid reductase [J]. Bulletin of Microbiology, 2020, 47(07): 2255-65.) Carboxylic acid reductase can catalyze the reduction of carboxylic acids to corresponding aldehydes. The systematic development, structure and catalytic mechanism, protein engineering and immobilization engineering of carboxylic acid reductase were studied, revealing its application as an important tool enzyme in biotransformation and synthetic biology. At present, no natural biosynthetic pathway of 1,6-hexanediamine has been reported. Summary of the invention
[0003] The purpose of the present invention is to provide a strain with high production of hexamethylenediamine, and the technical problem to be solved is how to construct a complete metabolic synthesis pathway of 1,6-hexamethylenediamine in an engineered bacterium. Another purpose of the present invention is to provide a method for preparing the above strain to solve the problem of how to obtain the above recombinant strain.
[0004] In order to solve the above technical problems, the present invention provides the following technical solutions:
[0005] A hexamethylenediamine high-yield strain, the strain expresses a carboxylic acid reductase mutant MAB CAR L342E, a transaminase PatA and a transaminase VFTA, the amino acid sequence of the MAB CAR L342E being as shown in SEQ ID NO.1.
[0006] Preferably, the amino acid sequence of PatA is shown as SEQ ID NO.2, and the amino acid sequence of VFTA is shown as SEQ ID NO.7.
[0007] Preferably, the deposited name of the strain is Escherichia coli DAH37, the deposit number is CCTCCNO: M20231767, and the strain was deposited in the China Center for Type Culture Collection on September 22, 2023, and the deposit address is Wuhan University, Wuhan, China.
[0008] In order to obtain the above-mentioned high-yield hexamethylenediamine strain, the present invention adopts the following method to prepare the strain, and the steps are as follows:
[0009] (1) constructing a recombinant bacterium expressing the carboxylic acid reductase mutant MAB CAR L342E;
[0010] (2) The expression vectors containing the transaminase PatA gene and the transaminase VFTA gene were transformed into the recombinant bacteria to obtain a strain that simultaneously expresses the carboxylic acid reductase mutant and the transaminase to produce 1,6-hexanediamine.
[0011] Preferably, the method of step (1) is: using a plasmid containing a wild-type carboxylic acid reductase gene as a template, designing a primer pair for PCR reaction, cloning a carboxylic acid reductase mutant gene, inserting the carboxylic acid reductase mutant gene into an expression vector, and then transforming a host bacterium to obtain a recombinant bacterium.
[0012] Preferably, the nucleic acid sequence of the primer pair is as shown in SEQ ID NO.11-12, and the annealing temperature of the PCR reaction is 55-67°C.
[0013] Preferably, the DNA sequence of the transaminase PatA gene in step (2) is as shown in SEQ ID NO.13; the DNA sequence of the transaminase VFTA gene is as shown in SEQ ID NO.14.
[0014] The strain constructed by the method of the present invention uses 6-aminocaproic acid as a substrate to biosynthesize 1,6-hexanediamine.
[0015] The invention provides a plasmid containing PatA gene and VFTA gene.
[0016] Beneficial effects obtained by the present invention: The present invention constructs the 1,6-hexanediamine biosynthetic strain DAH37 by optimizing the expression of carboxylic acid reductase and double aminotransferase genes, providing a new pathway for biosynthesizing 1,6-hexanediamine using 6-aminocaproic acid as a starting substrate. The ability of the DAH37 strain containing the double aminotransferase gene to synthesize 1,6-hexanediamine is significantly higher than that of the strain expressing only the single aminotransferase gene, showing good prospects for industrial application. BRIEF DESCRIPTION OF THE DRAWINGS
[0017] Figure 1 is the result of the enzyme activity assay of carboxylic acid reductase;
[0018] Figure 2 This is a diagram of the screening results of single aminotransferase strains;
[0019] Figure 3 This is the result of screening dual aminotransferase strains. DETAILED DESCRIPTION
[0020] The specific implementation modes of the present invention are further explained in detail below through the description of embodiments, so as to help those skilled in the art to have a more complete, accurate and in-depth understanding of the inventive concept and technical solution of the present invention.
[0021] Example 1: Prepare DAH4 strain as follows:
[0022] 1.1 Materials
[0023] 1.1.1 Strains and plasmids
[0024] Table 1 Strains and plasmids
[0025]
[0026]
[0027]
[0028]
[0029] 1.1.2 Culture medium
[0030] LB medium: peptone 10 g / L, yeast extract 5 g / L, NaCl 10 g / L; LB solid medium is added with agar powder at 2% (mass fraction), and antibiotics of corresponding concentrations are added as needed.
[0031] The sterilization conditions of the above culture medium are 121℃, 20min.
[0032] 1.1.3 Reagents and instruments
[0033] Tryptone and yeast extract were purchased from Oxoid, UK. The chemical reagents used in this experiment, such as sodium chloride, glucose, glycerol, ether, acetonitrile, hydrochloric acid, sodium hydroxide, sodium bicarbonate, and acetone, were all analytically pure and purchased from Shanghai Sinopharm Chemical Reagent Co., Ltd. Ampicillin (Amp), kanamycin sulfate (Kana), chloramphenicol (Chl) and other antibiotics were purchased from Shanghai Shenggong Bioengineering Co., Ltd. The molecular biology reagents used were: DNA marker (Dalian Takara Biological Company), GoldView DNA nucleic acid dye (Yuanye), DNA polymerase PrimeStarMax (Takara), and T4 DNA ligase (Takara).
[0034] PCR instrument, Eppendorf, Germany; DYY-6C electrophoresis instrument, Beijing Liuyi Electrophoresis Instrument Factory; GelDoc gel imaging system, Bio-Rad, USA; UV-visible spectrophotometer (UV2450), Shimadzu, Japan; Eppendorf high-speed centrifuge, Eppendorf, Germany; constant temperature incubator, Shanghai Institute of Medical Devices; multifunctional microplate reader Cytation 3imaging reader, BioTek, USA; constant temperature shaker, Shanghai Yuejin Medical Device Factory; LS-B50L vertical circular pressure steam sterilizer, Shanghai Medical Nuclear Instrument Factory.
[0035] 1.2 Methods
[0036] 1.2.1 Preliminary modification of carboxylic acid reductase
[0037] According to the results reported in the literature that the carboxylic acid reductase MAB CAR L342E mutant has enhanced activity on 6-aminohexanoic acid [FEDORCHUK TP, KHUSNUTDINOVA AN, EVDOKI MOVA E, et al. One-Pot Biocatalytic Transformation of Adipic Acid to 6-Ami nocaproic Acid and 1,6-Hexamethylenediamine Using Carboxylic Acid Reductas es and Transaminases [J]. JAm Chem Soc, 2020, 142 (2): 1038-48.], the applicant carried out a preliminary modification of the carboxylic acid reductase MAB CAR. The MAB CAR gene was inserted into the high-copy pRSF plasmid using Nco I and BamH I restriction endonucleases and T4 DNA ligase to construct the corresponding carboxylic acid reductase expression vector. The SFP gene was inserted into the MAB CAR gene using BamH I and EcoR I restriction endonucleases and T4 DNA ligase and connected by RBS (TAAGGAGATATC), and the amino acid sequence of the SFP is shown in SEQ ID NO.10. The plasmid pRSF-MAB CAR was amplified by full plasmid PCR using F-MAB CAR L342E and R-MAB CAR L342E primers. The correct amplified product was verified by nucleic acid electrophoresis and purified for standby use. In order to avoid false positive results, the applicant subjected the original methylated plasmid to Q.Cut Dpn I enzyme digestion at 37 ° C, the digestion reaction time was 60 min, and then treated at 70 ° C for 15 min to inactivate the enzyme, and finally used T4 DNA ligase for ligation reaction.
[0038] After the ligation reaction, the obtained ligation product was transformed into JM109 competent cells and spread on a plate containing 50 μg / mL kanamycin and cultured at 37°C for 10-12 hours. Subsequently, a single colony was selected for colony PCR verification to confirm the correctness of the transformation. The correct transformants were cultured and the recombinant plasmids were extracted for subsequent sequencing analysis. The applicant selected Suzhou Jinweizhi Biotechnology Co., Ltd. for sequencing services. The plasmid with the correct sequencing results was named pRSF-MAB CAR L342E.
[0039] Table 2 Primer list
[0040]
[0041] Table 3 PCR reaction system
[0042]
[0043] Table 4 PCR reaction conditions
[0044]
[0045] 1.2.2 Expression and purification of carboxylic acid reductase
[0046] The recombinant strains of E.coli BL21ΔsthA / pRSF-MAB CAR and E.coli BL21ΔsthA / pRS F-MAB CAR L342E stored in frozen tubes were streaked on LB plates containing 50μg / ml kanamycin, and then single colonies were picked and transferred to 10ml LB liquid medium containing 50μg / ml kanamycin, and cultured at 37℃, 250r / min for 10-12h. Then, the bacterial liquid was transferred to 50ml LB liquid medium containing the same antibiotic concentration at a 2% inoculation volume. After culturing at 37℃, 250r / min for 3.5h, isopropyl-β-D-thiogal actopyranoside (IPTG) was added at a final concentration of 1.0mmol / L, and then cultured at 30℃, 250r / min for 12h to induce the expression of CAR enzyme.
[0047] Subsequently, the cells were collected by centrifugation at 4°C and 8000 r / min for 10 min, the culture medium was discarded, the cells were washed twice with Binding / Wash Buffer and resuspended. The cells were disrupted by ultrasonic disruption, and the supernatant obtained after frozen centrifugation was the crude protein solution.
[0048] Next, the histidine-tagged protein is purified by gravity. Take a Ni-NTA pre-packed column of the corresponding specifications according to the required load, let the storage buffer flow out by gravity, and first rinse off the 20% ethanol with deionized water. Equilibrate the column with two column volumes of Binding / Wash Buffer (Tris 2.422g / L, imidazole 1.36g / L, NaCl 29.22g / L), and the column volume is 1ml. Add the sample solution to the column and collect the flow-through into a centrifuge tube. If there is excess sample, you can re-load it and recycle it once to increase the binding effect between the sample and the filler. Use two column volumes of Binding / Wash Buffer to wash the column and remove impurities. Finally, the histidine-tagged protein on the column was eluted with two column volumes of Elution Buffer (Tris 2.422 g / L, imidazole 13.616 g / L, NaCl 29.22 g / L). This step was repeated twice, and the eluate from each time was stored separately for sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis.
[0049] 1.2.3 Determination of enzyme activity of carboxylic acid reductase mutants
[0050] The activity of carboxylic acid reductase was determined spectrophotometrically using an assay based on NADPH oxidation by following the decrease in absorbance at 340 nm. CAR enzyme activity was determined in a 100 mM Tris-HCl buffer (pH 7.5), 1 mM NADPH, 2.5 mM ATP, 10 mM MgCl 2 , substrate (10 mM 6-aminohexanoic acid) and 10 μg of purified CAR enzyme in a reaction mixture (0.2 ml).
[0051] The applicant performed enzyme activity assays on the purified MAB CAR and MAB CAR L342E mutant and listed the results in Figure 1 The wild-type MAB CAR has a low catalytic activity for 6-aminohexanoic acid, with an enzyme activity of only 20U / g. In contrast, the MABCAR L342E mutant has a significantly improved activity for 6-aminohexanoic acid, with an enzyme activity of 139U / g, which is 5.95 times higher than the wild-type. Since the mutant has a higher catalytic activity for 6-aminohexanoic acid, the recombinant bacteria expressing the MAB CAR L342E mutant were selected for subsequent single aminotransferase co-expression.
[0052] 1.2.4 Culture conditions
[0053] Seed liquid culture: streak the frozen recombinant Escherichia coli onto LB solid culture medium, culture at 37°C for 12 hours, pick a single colony and inoculate it into 10 mL of LB liquid culture medium, and culture it at 37°C, 250 r / min for 10 to 12 hours to obtain the seed liquid.
[0054] Shake flask fermentation: The cultured seed solution was transferred to 50 ml of LB fermentation medium at a 2% inoculum and cultured in a shaker at 37°C and 250 r / min for 3.0 h. Subsequently, IPTG was added for induction, and the culture temperature was lowered to 30°C and cultured for 72 h.
[0055] 1.2.5 Transaminase plasmid construction
[0056] According to the similarity of catalytic substrates, eight transaminases were screened from the biological enzyme database (BRENDA), including butanediamine aminotransferase (PatA, GenBank ID: NP_417544) from E. coli, aspartate aminotransferase (SPTA, GenBank ID: WP_011049154) from Silicibacter pomeroyi, 4-aminobutyrate aminotransferase (GabT, Gen Bank ID: BAC70294) from Streptomyces avermitilis, diamine aminotransferase (HATA, Gen Bank ID: SCM51866) from Hafnia alvei, aspartate aminotransferase (CVTA, GenBank ID: 6S4G_D) from Chromobacterium violaceum ATCC 12472, pyruvate aminotransferase (VFTA, GenBank ID: 5ZTX_A) from Vibrio fluvialis, and pyruvate aminotransferase (VFTA, GenBank ID: 5ZTX_A) from Solanum lycopersicum. tuberosum 4-aminobutyrate transaminase (STTA, GenBank ID: XP_006351980) and transaminase from Paracoccus den itrificans (PDTA, GenBank ID: WP_011747074), the genes were synthesized from Shanghai Bioengineering, the gene and plasmid were digested according to the restriction endonuclease instructions of Takara, and the T4 DNA ligase ligation followed the operating steps of Takara's T4 DNA ligase kit. The PatA gene was inserted into the pACYC vector using Nco I and BamH I restriction endonucleases and T4 DNA ligase to construct pACYC-PatA. The genes of SPTA, GabT, HATA, CVTA, VFTA, STTA and PDTA were also inserted into the medium and low copy pACYC plasmids through Nco I and BamH I sites to construct the corresponding transaminase expression vectors. The amino acid sequences of the transaminases PatA, SPTA, GabT, HATA, CVTA, VFTA, STTA and PDTA are shown in SEQ ID NOs. 2-9.
[0057] 1.2.6 Single aminotransferase screening
[0058] The strains DAH1 to DAH8 expressing the carboxylic acid reductase MAB CAR L342E mutant and one of the eight transaminases were constructed and fermented in shake flasks. After 72 hours of fermentation, samples were taken at 0h, 12h, 24h, 48h, and 72h, and the fermentation broth was analyzed by HPLC. Three parallel experiments were set up for each experiment, and the average value was calculated for the final result. The detection method is as follows:
[0059] The liquid chromatograph used in this study was an Agilent high performance liquid chromatograph (HPLC, Agilent 1260 Infinity II, Santa Clara, California, USA), equipped with a UV detector (Agilent 1260 VWD, G7114A), a differential detector (Agilent Refractive Index (RI), G7162A), an injector (Agilent 1260 vial sampler, G7129A) and a quadruple pump (Agilent 1260 Quad Pump VL, G7111A). The diamines were separated and detected by an Agilent porpshell 120 EC-C18 (4.6×150 mm, 4 μm particle size) column.
[0060] Take 500 μL of fermentation broth, centrifuge at 12000 rpm / min for 5-10 min, take 30 μL of supernatant, dilute 10 times with deionized water to 300 μL, add 300 μL of saturated NaHCO 3 ,3μL 10mg / L 1,7-heptanediamine (TCI, 98.0% (GC&T)) was used as the internal standard. The pH was adjusted to 9.4 with 15g / L NaOH solution. After adding 600μL of 5mg / ml dansyl chloride acetone solution, the derivatization reaction was carried out at 60℃ in a dark place for 30min. After the derivatization, 150μL saturated NaCl was added to terminate the reaction. Extract twice with 2ml and 1ml anhydrous ether respectively, blow off the upper layer with liquid nitrogen, and remove the ether. Then re-dissolve with 300μL acetonitrile and filter with a 0.22μm organic phase membrane. Butanediamine (100mg / L, from TCI with purity 98.0% (GC&T)) and pentamethylenediamine (100mg / L, from TCIwith purity 98.0% (GC&T)) standards were also treated in the same way. The HPLC detection conditions were as follows: the column temperature was set at 30°C, the ultraviolet detection wavelength was set at 254 nm, the injection volume was 10 μL, the mobile phase A was ultrapure water, the mobile phase B was acetonitrile, and the gradient elution scheme was set as follows: 0-4 min, the mobile phase B increased from 55% to 70%; then maintained at 70% for 2 min; 6-11 min, the mobile phase B increased from 70% to 95%; then maintained at 95% for 1 min; 12-13 minutes, the mobile phase B decreased from 95% to 55%; finally, maintained at 55% for 2 min, and the flow rate was set to 0.7 mL / min.
[0061] In the artificial synthesis pathway of 1,6-hexanediamine, transaminase plays an important role in the last step of the synthesis process, which indicates that transaminase may have an important influence on the yield of 1,6-hexanediamine. In order to increase the yield of 1,6-hexanediamine, the applicant first optimized the transaminase in the artificial synthesis pathway of 1,6-hexanediamine. The applicant screened 8 single transaminase strains and found that the DAH2 and DAH4 strains were able to produce 1,6-hexanediamine, among which the DAH4 strain had the highest 1,6-hexanediamine yield, reaching 3.01 mg / L, which was 3.6 times that of the DAH2 strain.
[0062] Example 2: Screening of strains expressing dual aminotransferases simultaneously
[0063] Transaminase plasmid construction: PatA gene was inserted into pET vector using Nco I and BamH I restriction endonucleases and T4 DNA ligase to construct pET-PatA. SPTA, GabT, HATA, CVTA, VFT A, STTA and PDTA genes were also inserted into the middle copy pET plasmid through Nco I and BamH I sites to construct the corresponding transaminase expression vectors.
[0064] Based on the carboxylic acid reductase MAB CAR L342E mutant, the eight transaminases in Example 1 were combined in pairs to construct 28 strains DAH9-DAH36 for shake flask fermentation. After 72 hours of fermentation, samples were taken at 0h, 12h, 24h, 48h, and 72h, and the fermentation broth was analyzed by HPLC. Three parallel experiments were set up for each experiment, and the final result was calculated as the average value.
[0065] The applicant determined the production of 1,6-hexanediamine by conducting shake flask fermentation experiments with 28 transaminase strains (DAH9-DAH36) and reported the results in Figure 3 Among them, strains DAH11, DAH13, DAH14, DAH15, DAH24, DAH25, DAH26, DAH29, DAH30, DAH31, DAH32 and DAH33 showed the ability to produce 1,6-hexanediamine. Among these strains, the DAH13 strain had the highest 1,6-hexanediamine production, reaching 5.80 mg / L, which is 1.9 times the production of the single aminotransferase strain DAH4. Based on these results, the applicant finally determined that the most suitable dual aminotransferases were PatA and VFTA. On this basis, the applicant constructed strain DAH37 for expressing PatA and VFTA dual aminotransferases, and conducted shake flask fermentation experiments.
[0066] After further optimizing the fermentation conditions, the applicant found that under the optimal conditions of initial substrate concentration of 8 g / L, initial glucose concentration of 2 g / L, induction time of 1.5 h, and fermentation time of 96 h, the production of 1,6-hexanediamine of DAH4 strain reached 64.3 mg / L, while under the optimal conditions of initial substrate concentration of 8 g / L, initial glucose concentration of 2 g / L, induction time of 3.5 h, and fermentation time of 96 h, the production of 1,6-hexanediamine of DAH37 strain reached 153.9 mg / L, which was significantly higher than that of the single aminotransferase strain. It can be seen that the DAH37 strain has high-yield characteristics and good prospects for industrial application.
[0067] The above embodiments are only for illustrating the technical idea of the present invention, and cannot be used to limit the protection scope of the present invention. Any changes made on the basis of the technical solution in accordance with the technical idea proposed by the present invention shall fall within the protection scope of the present invention; any technology not involved in the present invention can be realized by existing technologies.
Claims
1. A hexamethylenediamine high-yielding strain, characterized in that: The strain is Escherichia coli, which expresses a carboxylic acid reductase mutant MAB CAR L342E, a transaminase PatA and a transaminase VFTA, wherein the amino acid sequence of the MAB CAR L342E is shown in SEQ ID NO.1; the amino acid sequence of the PatA is shown in SEQ ID NO.2, and the amino acid sequence of the VFTA is shown in SEQ ID NO.
7.
2. A hexamethylenediamine high-yielding strain, characterized in that: The deposited name of the strain is Escherichia coli DAH37, the deposit number is CCTCC NO: M20231767. The strain was deposited in the China Center for Type Culture Collection on September 22, 2023.
3. The method for preparing the hexamethylenediamine high-yielding strain according to claim 1, characterized in that: The steps include: (1) constructing a recombinant bacterium expressing the carboxylic acid reductase mutant MAB CAR L342E; (2) The expression vectors containing the transaminase PatA gene and the transaminase VFTA gene were transformed into the recombinant bacteria to obtain a strain that simultaneously expresses the carboxylic acid reductase mutant and the transaminase and produces 1,6-hexanediamine.
4. The method for preparing the hexamethylenediamine high-yielding strain as claimed in claim 3, characterized in that: The method of step (1) is: using a plasmid containing a wild-type carboxylic acid reductase gene as a template, designing a primer pair for PCR reaction, cloning a carboxylic acid reductase mutant gene, inserting the carboxylic acid reductase mutant gene into an expression vector, and then transforming a host bacterium to obtain a recombinant bacterium 1; The nucleotide sequence of the upstream primer in the primer pair is shown as SEQ ID NO. 11, and the nucleotide sequence of the downstream primer is shown as SEQ ID NO.
12. The annealing temperature of the PCR reaction is 55-67°C.
5. The method for preparing the hexamethylenediamine high-yielding strain as claimed in claim 3, characterized in that: The DNA sequence of the transaminase PatA gene in step (2) is shown as SEQ ID NO.13; the DNA sequence of the transaminase VFTA gene is shown as SEQ ID NO.
14.
6. Use of the hexamethylenediamine high-producing strain as claimed in any one of claims 1 to 2 in synthesizing 1,6-hexamethylenediamine using 6-aminocaproic acid as a substrate.
